Ranking Profile - Corbus Pharmaceuticals Holdings Inc

Introduction

Corbus Pharmaceuticals Holdings Inc (Corbus Pharmaceuticals) is a clinical-stage pharmaceutical company that develops and commercializes novel therapeutics to treat inflammatory and fibrotic diseases. The company’s pipeline product portfolio includes Lenabasum, an oral small-molecule for the treatment of inflammatory diseases; CRB-4001, to treat fibrotic diseases. It serves in the therapeutic areas of chronic inflammation, autoimmune diseases, allergies and orphan diseases. Corbus Pharmaceuticals collaborates with National Institutes of Health (NIH) for in the development of drugs. The company has operations in Europe, Israel, and Australia. Corbus Pharmaceuticals is headquartered in Norwood, Massachusetts, the US.